skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
We are delighted to announce the finalists for the 2017 Clinical and Research Excellence Awards:

Best Patient Centric Clinical Trial

Braeburn Pharmaceuticals, Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients with Opioid Use Disorder

CK Aspire, Domiciliary Service on behalf of the Salford Lung Study (SLS) sponsored by GlaxoSmithKline (GSK)

Janssen Research & Development, A Study to Evaluate the Safety and Clinical Response of Subretinal Administration of CNTO 2476 (Palucorcel) in Participants with Geographic Atrophy (PRELUDE)


Best Patient-Focused Technological Development           

AMRA, AMRA® Profiler Research

CRF Health, TrialConsent™, electronic informed consent platform

NorthWest EHealth, Linked Database System

PAREXEL International, Consent+

Best Sponsor-Focused Technological Development          

Covance, Xcellerate® Medical Review

Cytel, East 6.4 Team

goBalto, goBalto Select

IBM Watson Health & Novartis & Highlands Oncology, Watson Clinical Trial Matching Team

Medidata Solutions, Medidata Balance: Pooling Trial Supplies at Sites

Clinical Partnership of the Year – Sponsored by EBD Group

AstraZeneca Business Development Project Team

Bellerophon Therapeutics and Worldwide Clinical Trials

Medidata Solutions & TESARO

Novartis; Kenya Medical Research Institute Center for Clinical Research/Strathmore University; Kintampo Health Research Center; Ifakara Health Institute; Division of Clinical Pharmacology at the University of Cape Town; Addis Ababa University/ Regional Bioequivalence Center; African Institute of Biomedical Science and Technology
Clinical Pharmacology Capability Building in Sub-Saharan Africa


Clinical Trial Result of the Year – Sponsored by Medidata Solutions    

Centrexion Therapeutics, TRIUMPH – Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects with Chronic, Moderate-to-Severe Osteoarthritis Knee Pain

Kiadis Pharma, Evaluation of the safety and efficacy of ATIR101™ in patients with a hematologic malignancy, who received a CD34-selected hematopoietic stem cell transplantation from a haploidentical donor

Kite Pharma, ZUMA-1 Pivotal CAR-T Therapy Trial of Axicabtagene Ciloleucel in Patients with Aggressive Non-Hodgkin Lymphoma (NHL)

Radius Health, Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women with Osteoporosis

TESARO, Phase 3 NOVA Trial of Niraparib for Patients with Recurrent Ovarian Cancer

Excellence in Rare Disease Drug Development      

Onxeo, AsiDNA, a first-in-class signal-interfering DNA repair pathway inhibitor for cancer treatment

Retrophin, Phase 2 Study (NCT01613118) of Sparsentan for focal segmental glomerulosclerosis (FSGS)

Tocagen, Toca 511 + Toca FC for recurrent high grade glioma 

Most Innovative Clinical Trial Design         

Braeburn Pharmaceuticals, A Phase III Trial of CAM2038, a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injectable Depot of Buprenorphine Treatment for Adult Outpatients with Opioid Use Disorder

Ipca Laboratories, Evaluation of Efficacy and Safety of Spironolactone + Chlorthalidone Combination in the Treatment of Patients with Essential Hypertension, Pre-diabetes, and Insulin Resistance: A Double-blind, Randomized Comparison with Individual Monotherapies

Ipca Laboratories, Efficacy and Safety of Hydroxychloroquine in Prevention of Diabetes in Patients with Pre-diabetic Dyslipidemia: A Double Blind, Randomized Comparison with Atorvastatin Alone

Multiple Myeloma Research Foundation, CoMMpass ((Relating) Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profiles) study

Tracon Pharmaceuticals (in collaboration with Cytel), A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib alone in Patients with Advanced Angiosarcoma (TAPPAS)

Most Successful Early Phase Trial (Preclinical & Phase I)

Nektar, NKTR-214 in Subjects with Locally Advanced or Metastatic Solid Tumor Malignancies

Onxeo, A first-in-human Phase I clinical trial of AsiDNA in patients with metastatic melanoma

Tocagen, Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Pharma/Biotech Product Development Team of the Year – Sponsored by Cytel

ICON/Pfizer Tofa Oral Strategy Team

Retrophin, Sparsentan Product Development Team

TESARO, Niraparib Product Development Team

Marquee Award for R&D Excellence


Lifetime Achievement Award

Dr. Michael Murphy, M.D., Ph.D. Chief Medical & Scientific Officer, Worldwide Clinical Trials

Winners will be announced at the awards ceremony and dinner on 5 April, at the State Room in Boston.
Don’t forget to book your place to attend.

Good luck to all of our finalists!

Trophies are designed and manufactured by Gaudio